Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey I Weitz

Circulation

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Circulation|September 16, 2024
Arterial Thrombosis: Present and FutureJeffrey I Weitz
Circulation|September 2, 2004
Management of venous thromboembolism: present and futureJeffrey I Weitz
Circulation|September 2, 2004
New anticoagulants for treatment of venous thromboembolismJeffrey I Weitz
Circulation|August 31, 2011
Importance of family history as a risk factor for venous thromboembolismJohn W Eikelboom, Jeffrey I Weitz
Circulation|April 7, 2010
New anticoagulantsJohn W Eikelboom, Jeffrey I Weitz
Circulation|July 27, 2005
Coagulation assaysShannon M Bates, Jeffrey I Weitz
Circulation|July 14, 2020
Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect StormAlex C Spyropoulos, Jeffrey I Weitz
Circulation|February 28, 2002
Direct thrombin inhibitors in acute coronary syndromes: present and futureJeffrey I Weitz, Harry R Buller
Circulation|December 19, 2022
What Is the Future of Factor XI Inhibitors?Jeffrey I Weitz, John W Eikelboom
Circulation|November 25, 2016
Response by Weitz and Eikelboom to Letter Regarding Article, "Urgent Need to Measure Effects of Direct Oral Anticoagulants"Jeffrey I Weitz, John W Eikelboom
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Circulation|September 16, 2024
Arterial Thrombosis: Present and FutureJeffrey I Weitz
Circulation|September 2, 2004
Management of venous thromboembolism: present and futureJeffrey I Weitz
Circulation|September 2, 2004
New anticoagulants for treatment of venous thromboembolismJeffrey I Weitz
Circulation|August 31, 2011
Importance of family history as a risk factor for venous thromboembolismJohn W Eikelboom, Jeffrey I Weitz
Circulation|April 7, 2010
New anticoagulantsJohn W Eikelboom, Jeffrey I Weitz
Circulation|July 27, 2005
Coagulation assaysShannon M Bates, Jeffrey I Weitz
Circulation|July 14, 2020
Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect StormAlex C Spyropoulos, Jeffrey I Weitz
Circulation|February 28, 2002
Direct thrombin inhibitors in acute coronary syndromes: present and futureJeffrey I Weitz, Harry R Buller
Circulation|December 19, 2022
What Is the Future of Factor XI Inhibitors?Jeffrey I Weitz, John W Eikelboom
Circulation|November 25, 2016
Response by Weitz and Eikelboom to Letter Regarding Article, "Urgent Need to Measure Effects of Direct Oral Anticoagulants"Jeffrey I Weitz, John W Eikelboom
Pageof 3